| 000 | 00871 a2200265 4500 | ||
|---|---|---|---|
| 005 | 20250517200736.0 | ||
| 264 | 0 | _c20190311 | |
| 008 | 201903s 0 0 eng d | ||
| 022 | _a1600-0641 | ||
| 024 | 7 |
_a10.1016/j.jhep.2018.01.021 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aLemoine, M | |
| 245 | 0 | 0 |
_aThe Egyptian hepatitis C programme: A model of HCV treatment intervention? _h[electronic resource] |
| 260 |
_bJournal of hepatology _c04 2018 |
||
| 300 |
_a638-639 p. _bdigital |
||
| 500 | _aPublication Type: Editorial; Comment | ||
| 650 | 0 | 4 | _aAntiviral Agents |
| 650 | 0 | 4 | _aEgypt |
| 650 | 0 | 4 | _aHepacivirus |
| 650 | 0 | 4 | _aHepatitis C |
| 650 | 0 | 4 | _aHumans |
| 700 | 1 | _aCooke, G S | |
| 773 | 0 |
_tJournal of hepatology _gvol. 68 _gno. 4 _gp. 638-639 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1016/j.jhep.2018.01.021 _zAvailable from publisher's website |
| 999 |
_c28053044 _d28053044 |
||